We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Dalton Announces Manufacturing and Development Agreement with RLPC

News   Jul 16, 2015

 
Dalton Announces Manufacturing and Development Agreement with RLPC
 
 
Advertisement
 

RELATED ARTICLES

Which Drugs Are Most Toxic to the Liver?

News

A new study provides insights on how hospitalized patients can develop liver injury from taking different drugs.

READ MORE

Determining Safe Drug Doses for Children

News

Aalto University researchers in collaboration with the pharmaceutical company Novartis have developed a method that makes better use of available data to help determine safe pediatric drug doses more quickly and with fewer observations.

READ MORE

Cell Extrusion "Trigger" Could Protect Against Cancer

News

One way that organisms get rid of unneeded cells is via a process called extrusion, which allows cells to be squeezed out without disrupting the layer of cells left behind. A team from MIT has now discovered that this process is activated when cells are unable to replicate their DNA during cell division.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE